Cargando…

HIF1α-Dependent Induction of TFRC by a Combination of Intestinal Inflammation and Systemic Iron Deficiency in Inflammatory Bowel Disease

Background and Aims: Iron deficiency (ID) is a frequent extra-intestinal manifestation in patients with Inflammatory Bowel Disease (IBD), who often do not respond to iron supplementation. Iron is a cofactor for hydroxylases that suppress the hypoxia-inducible factor-1α (HIF1α), a transcription facto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fagundes, Raphael R., Bourgonje, Arno R., Hu, Shixian, Barbieri, Ruggero, Jansen, Bernadien H., Sinnema, Nienke, Blokzijl, Tjasso, Taylor, Cormac T., Weersma, Rinse K., Faber, Klaas Nico, Dijkstra, Gerard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214203/ https://www.ncbi.nlm.nih.gov/pubmed/35755436 http://dx.doi.org/10.3389/fphys.2022.889091

Ejemplares similares

Pirfenidone Inhibits Cell Proliferation and Collagen I Production of Primary Human Intestinal Fibroblasts
por: Cui, Yingying, et al.
Publicado: (2020)

Mucosal Eosinophil Abundance in Non-Inflamed Colonic Tissue Is Associated with Response to Vedolizumab Induction Therapy in Inflammatory Bowel Disease
por: Gabriëls, Ruben Y., et al.
Publicado: (2022)

Inulin-grown Faecalibacterium prausnitzii cross-feeds fructose to the human intestinal epithelium
por: Fagundes, Raphael R., et al.
Publicado: (2021)

Inflammation status modulates the effect of host genetic variation on intestinal gene expression in inflammatory bowel disease
por: Hu, Shixian, et al.
Publicado: (2021)

A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2019)

Proteomic analyses do not reveal subclinical inflammation in fatigued patients with clinically quiescent inflammatory bowel disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Clinical Value of Multiomics-Based Biomarker Signatures in Inflammatory Bowel Diseases: Challenges and Opportunities
por: Bourgonje, Arno R., et al.
Publicado: (2023)

Safe and Successful Treatment of Acute Cellular Rejection of an Intestine and Abdominal Wall Transplant With Vedolizumab
por: Trentadue, Guido, et al.
Publicado: (2020)

Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn’s Disease
por: Alexdottir, Marta S., et al.
Publicado: (2022)

Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn’s Disease
por: Alexdottir, Marta S., et al.
Publicado: (2022)

Increased fecal calprotectin levels in Crohn’s disease correlate with elevated serum Th1- and Th17-associated cytokines
por: Bourgonje, Arno R., et al.
Publicado: (2018)

Assessing intestinal permeability in Crohn’s disease patients using orally administered (52)Cr-EDTA
por: von Martels, Julius Z. H., et al.
Publicado: (2019)

A simple coculture system shows mutualism between anaerobic faecalibacteria and epithelial Caco-2 cells
por: Sadaghian Sadabad, Mehdi, et al.
Publicado: (2015)

Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohnʼs disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Serum Free Thiols Are Superior to Fecal Calprotectin in Reflecting Endoscopic Disease Activity in Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2019)

Riboflavin Supplementation in Patients with Crohn’s Disease [the RISE-UP study]
por: von Martels, Julius Z H, et al.
Publicado: (2020)

Crohn’s Disease in Clinical Remission Is Marked by Systemic Oxidative Stress
por: Bourgonje, Arno R., et al.
Publicado: (2019)

Long-Term Dietary Patterns Are Reflected in the Plasma Inflammatory Proteome of Patients with Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Donor genetic variants as risk factors for thrombosis after liver transplantation: A genome‐wide association study
por: Li, Yanni, et al.
Publicado: (2021)

Patients With Inflammatory Bowel Disease Show IgG Immune Responses Towards Specific Intestinal Bacterial Genera
por: Bourgonje, Arno R., et al.
Publicado: (2022)

The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease
por: Bourgonje, Arno R, et al.
Publicado: (2021)

MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma
por: Lu, Yuxiong, et al.
Publicado: (2021)

Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease
por: Otten, Antonius T., et al.
Publicado: (2022)

Intestinal stenosis in Crohn’s disease shows a generalized upregulation of genes involved in collagen metabolism and recognition that could serve as novel anti-fibrotic drug targets
por: van Haaften, Wouter Tobias, et al.
Publicado: (2020)

Isotype-specific Antibody Responses to Mycobacterium avium paratuberculosis Antigens Are Associated With the Use of Biologic Therapy in Inflammatory Bowel Disease
por: van der Sloot, Kimberley W J, et al.
Publicado: (2020)

Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options
por: Bourgonje, Arno R., et al.
Publicado: (2021)

Role of TFRC as a Novel Prognostic Biomarker and in Immunotherapy for Pancreatic Carcinoma
por: Yang, Cheng, et al.
Publicado: (2022)

Predicted efficacy of a pharmacogenetic passport for inflammatory bowel disease
por: Bangma, Amber, et al.
Publicado: (2020)

Development and validation of a web-based questionnaire to identify environmental risk factors for inflammatory bowel disease: the Groningen IBD Environmental Questionnaire (GIEQ)
por: van der Sloot, Kimberley Wilhelmina Johanna, et al.
Publicado: (2018)

Clinical and Immunological Characterization of Combined Immunodeficiency Due to TFRC Mutation in Eight Patients
por: Aljohani, Amal H., et al.
Publicado: (2020)

NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma
por: Arora, Rahul, et al.
Publicado: (2023)

TFRC and ACTB as the best reference genes to quantify Urokinase Plasminogen Activator in breast cancer
por: Majidzadeh-A, Keivan, et al.
Publicado: (2011)

A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency
por: Jabara, Haifa H., et al.
Publicado: (2015)

YTHDF1-enhanced iron metabolism depends on TFRC m(6)A methylation
por: Ye, Jing, et al.
Publicado: (2020)

How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
por: Geng, Yana, et al.
Publicado: (2021)

TFRC upregulation promotes ferroptosis in CVB3 infection via nucleus recruitment of Sp1
por: Yi, Lu, et al.
Publicado: (2022)

Knockdown of ANXA10 induces ferroptosis by inhibiting autophagy-mediated TFRC degradation in colorectal cancer
por: Wang, Xinyuan, et al.
Publicado: (2023)

Sorting nexin 3 exacerbates doxorubicin-induced cardiomyopathy via regulation of TFRC-dependent ferroptosis
por: Yu, Wenjing, et al.
Publicado: (2023)

Faecal metabolome and its determinants in inflammatory bowel disease
por: Vich Vila, Arnau, et al.
Publicado: (2023)

Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets
por: Bourgonje, Arno R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0lg5sdm2ljdqfoj4dpf23o3ipl